Summary
The purpose of this chapter is to provide an introduction to magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) of human brain tumors, including the primary applications and basic terminology involved. Readers who wish to know more about this broad subject should seek out the referenced books (1. Tofts (2003) Quantitative MRI of the brain. Measuring changes caused by disease. Wiley; Bradley and Stark (1999) 2. Magnetic resonance imaging, 3rd Edition. Mosby Inc; Brown and Semelka (2003) 3. MRI basic principles and applications, 3rd Edition. Wiley-Liss) or reviews (4. Top Magn Reson Imaging 17:127–36, 2006; 5. JMRI 24:709–724, 2006; 6. Am J Neuroradiol 27:1404–1411, 2006).
MRI is the most popular means of diagnosing human brain tumors. The inherent difference in the magnetic resonance (MR) properties of water between normal tissues and tumors results in contrast differences on the image that provide the basis for distinguishing tumors from normal tissues. In contrast to MRI, which provides spatial maps or images using water signals of the tissues, proton MRS detects signals of tissue metabolites. MRS can complement MRI because the observed MRS peaks can be linked to inherent differences in biochemical profiles between normal tissues and tumors.
The goal of MRI and MRS is to characterize brain tumors, including tumor core, edge, edema, volume, types, and grade. The commonly used brain tumor MRI protocol includes T2-weighted images and T1-weighted images taken both before and after the injection of a contrast agent (typically gadolinium: Gd). The commonly used MRS technique is either point-resolved spectroscopy (PRESS) or stimulated echo acquisition mode (STEAM).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tofts, P. (2003) Quantitative MRI of the brain. Measuring changes caused by disease. Wiley, Chichester, UK.
Bradley, W. G., and Stark, D. D. (1999) Magnetic resonance imaging, 3rd Edition. Mosby Inc, St. Louis.
Brown, M. A., and Semelka, R. C. (2003) MRI basic principles and applications, 3rd Edition. Wiley-Liss, New York.
Newton, H. B., Ray-Chaudhury, A., and Cavaliere, R. (2006) Brain tumor imaging and cancer management: the neuro-oncologists perspective. Top Magn Reson Imaging. 17(2):127–136.
Young, R. J., and Knopp, E. A. (2006) Brain MRI: tumor evaluation. JMRI. 24:709–724.
Hollingworth, W., Medina, L. S., Lenkinski, R. E., Shibata, D. K., Bernal, B., Zurakowski, D., Comstock, B., and Jarvik, J. G. (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. Am J Neuroradiol. 27(8):1404–1411.
Stanisz, G. J., Odrobina, E. E., Pun, J., Escaravage, M., Graham, S. J., Bronskill, M. J., and Henkelman, R. M. (2005) T1, T2 relation and magnetization transfer in tissue at 3T. Magn Reson Med. 54:507–512.
Nelson, S. (2004) Magnetic resonance spectroscopic imaging: evaluating response to therapy for gliomas. IEEE Eng Med Biol Mag, 23(5):30–39.
McKnight, T., von Dem Bussche, M., Vigneron, D., Lu, Y., Berger, M., McDermott, M., Dillon, W., Graves, E., Pirzkall, A., and Nelson, S. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg. 97:794–802.
Kovacevic, Z., and McGivan, J. (1983) Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev. 63:547–605.
Mates, J., Perez-Gomez, C., Castro, I., Asenjo, M., and Marquez, J. (2002) Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation /death. Int J Biochem Cell Biol. 34:439–458.
Medina, M. (2001) Glutamine metabolism: nutritional and clinical significant. J Nutr. 131:2539–2542.
Hu, J., Yang, S., Xuan, Y., Jiang, Q., Yang, Y., and Haacke, E. (2007) Simultaneous detection of resolved glutamate, glutamine, and g-aminobutyric acid at 4 Tesla. J Magn Reson. 185:217–226.
Brandao, L., and Domingues, R. (2004) MR spectroscopy of the brain. Chapter 10. Lippincott Williams & Wilkins, Philadelphia, PA.
Jung, T. Y., Jung, S., Kim, I. Y., Park, S. J., Kang, S. S., Kim, S. H., and Lim, S. C. (2006) Application of neuronavigation system to brain tumor surgery with clinical experience of 420 cases. Minim Invasive Neurosurg. 49(4): 210–215.
Nakasu, Y. (2007) Current strategies in radiation therapy for brain metastases. No Shinkei Geka. 35(1):7–16.
Ram, Z., Cohen, Z. R., Harnof, S., Tal, S., Faibel, M., Nass, D., Maier, S. E., Hadani, M., and Mardor, Y. (2006) Magnetic resonance imaging-guided, high-intensity focused ultrasound for brain tumor therapy. Neurosurgery. 59(5):949–955.
Lichy M. P., Bacher, P., Henze, M., Lichy, C. M., Debus, J., and Schlemmer, H. P. (2004) Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy. Neuroradiology. 46(2):126–9.
Ulmer, S., Braga, T. A., Barker, T. A., Barker, F. G. II., Lev, M. H., Gonzalez, R. G., andHenson, J. W. (2006) Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology. 67(9):1668–1670.
Saunders, D. E., Phipps, K. P., Wade, A. M., and Hayward, R. D. (2005) Surveillance imaging strategies following surgery and/or radiotherapy for childhood cerebellar low-grade astrocytoma. J Neurosurg. 102(2 Suppl):172–178.
Mabbott, D. J., Noseworthy, M. D., Bouffet, E., Rockel, C., and Laughlin, S. (2006) Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ. Neurooncology. (3):244–252.
Genc, M., Genc, E., Genc, B. O., and Kiresi, D. A. (2006) Significant response of radiation induced CNS toxicity to high dose steroid administration. Br J Radiol. 79(948):e196–e199.
Kim, M. J., Holodny, A. I., Hou, B. L., Peck, K. K., Moskowitz, C. S., Bogomolny, D. L., and Gutin, P. H. (2005) The effect of prior surgery on blood oxygen level-dependent functional MR imaging in the preoperative assessment of brain tumors. Am J Neuroradiol. 26(8):1980–1985.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Hou, B.L., Hu, J. (2009). MRI and MRS of Human Brain Tumors. In: Tainsky, M. (eds) Tumor Biomarker Discovery. Methods in Molecular Biology, vol 520. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-811-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-60327-811-9_21
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-810-2
Online ISBN: 978-1-60327-811-9
eBook Packages: Springer Protocols